AUSTRALIAN medicinal cannabis company, Cannatrek announced yesterday that its hero product, T25 Topaz Flower, is on the cusp of reaching 500k units sold in Australia.
The company stated this milestone is a testament to the continuous quality and reliability of T25 Topaz which holds the distinction of being the number one most prescribed and consistent medicinal cannabis product in Australia.
"We are committed to developing and delivering innovative, reliable and high-quality medicinal cannabis products that meet the needs of Australian patients" said Tommy Huppert, CEO of Cannatrek.
The company is also committed to providing a dependable and uninterrupted supply of product.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Mar 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Mar 23
